This downloadable report examines the often overlooked downside of R&D tax credits for venture capital firms.
While credits are frequently viewed as non-dilutive funding, increased scrutiny from HM Revenue and Customs means poorly prepared claims can create disruption across an entire portfolio.
Inside the PDF, we explore:
• How R&D enquiries impact funding rounds
• The portfolio-level risk that many investors are not aware of
• Where claims most commonly fall short
• What a robust, defensible claim should look like under scrutiny
Complete the form below to receive your copy.
